Longitudinal Joint Pain in Postmenopausal Women with Early Breast Cancer Taking Aromatase Inhibitors

被引：0
|
作者：
Castel, Liana D. [1 ]
Hartmann, Katherine [2 ]
Deppen, Stephen [3 ]
Mayer, Ingrid
Johnson, David [4 ]
Boomershine, Chad [5 ]
Abramson, Vandana G. [4 ]
Chakravarthy, Anuradha [6 ]
McLellan, Sarah Elizabeth [7 ]
Friedman, Debra L. [4 ]
Cella, David [8 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Gen Internal Med & Publ Hlth, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Obstet Gynecol, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Thorac Surg, Nashville, TN USA
[4] Vanderbilt Ingram Canc Ctr, Hematol Oncol, Nashville, TN USA
[5] Vanderbilt Univ, Med Ctr, Rheumatol & Immunol, Nashville, TN USA
[6] Vanderbilt Ingram Canc Ctr, Radiat Oncol, Nashville, TN USA
[7] Vanderbilt Univ, Med Ctr, Inst Med & Publ Hlth, Nashville, TN USA
[8] Northwestern Univ, Feinberg Sch Med, Med Social Sci, Chicago, IL 60611 USA
来源：
QUALITY OF LIFE RESEARCH | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
1701
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [41] In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures
    Wilcken, Nicholas
    Lee, Clara Inkyung
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [42] Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women
    不详
    [J]. Drugs & Therapy Perspectives, 2009, 25 (10) : 23 - 26
  • [43] The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer
    Benson, JR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6807 - 6809
  • [44] Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
    Loaiza-Bonilla, Arturo
    Socola, Francisco
    Glueck, Stefan
    [J]. CLINICAL MEDICINE INSIGHTS-WOMENS HEALTH, 2013, 6 : 1 - 11
  • [45] Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer
    Kudchadkar, R
    O'Regan, RM
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (03) : 145 - 163
  • [46] Oxylipins Correlate with Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer
    Martinez, J. A.
    Stopeck, A. T.
    Chow, H. H. S.
    Wertheim, B. C.
    Chew, W.
    Roe, D. J.
    Chalasani, P.
    Thompson, P. A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (03) : 691 - 691
  • [47] Aromatase inhibitors: A new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women
    Colozza, M.
    Califano, R.
    Minenza, E.
    Dinh, P.
    Azambuja, E.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (06) : 564 - 574
  • [48] Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer
    Nogues, Xavier
    Servitja, Sonia
    Jesus Pena, Maria
    Prieto-Alhambra, Daniel
    Nadal, Rosa
    Mellibovsky, Leonardo
    Albanell, Joan
    Diez-Perez, Adolfo
    Tusquets, Ignasi
    [J]. MATURITAS, 2010, 66 (03) : 291 - 297
  • [49] Effect of Aromatase Inhibitors on 24 Hour Ambulatory Blood Pressure in Postmenopausal Women with Early Stage Breast Cancer
    Mirza, Faryal Sardar
    Dojki, Farheen Kassim
    Taxel, Pamela
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [50] Periodontal Health in Women With Early-Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study
    Taichman, L. Susan
    Inglehart, Marita R.
    Giannobile, William V.
    Braun, Thomas
    Kolenic, Giselle
    Van Poznak, Catherine
    [J]. JOURNAL OF PERIODONTOLOGY, 2015, 86 (07) : 906 - 916
12345